Emergent BioSolutions (EBS) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)
Emergent BioSolutions (EBS) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -18.34% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.19% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -0.59% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 41.67% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -7.68% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -1.31% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.98% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.94% |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | -17.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.63% |
| Mar 31, 2026 | -9.77% |
| Dec 31, 2025 | -24.09% |
| Sep 30, 2025 | -24.56% |
| Jun 30, 2025 | -29.43% |
| Mar 31, 2025 | -41.75% |
| Dec 31, 2024 | -29.31% |
| Sep 30, 2024 | -29.67% |
| Jun 30, 2024 | -22.58% |
| Mar 31, 2024 | -47.07% |
| Dec 31, 2023 | -53.18% |
| Sep 30, 2023 | -50.99% |
| Jun 30, 2023 | -50.46% |
| Mar 31, 2023 | -11.23% |
| Dec 31, 2022 | 2.19% |
| Sep 30, 2022 | 4.96% |
| Jun 30, 2022 | 7.38% |
| Mar 31, 2022 | 16.54% |
| Dec 31, 2021 | 24.22% |
| Sep 30, 2021 | 26.74% |